Brand
Hikma Pharmaceuticals USA Inc. recalls
5 federal recalls on file, showing the 1 from the last 12 months. We monitor every CPSC, FDA, USDA, and NHTSA notice for Hikma Pharmaceuticals USA Inc. and translate it into plain English — free weekly digest, optional same-day alerts.
- 2026-09-02FDA-DrugClass IIHikma Ramipril Capsules recalled for impurity levels
Hikma Pharmaceuticals is recalling specific lots of Ramipril Capsules 10 mg because testing found higher-than-allowed levels of dicyclohexylurea, a process impurity. The affected lots are AC5470A and AC5470B, both expiring July 2027. No injuries have been reported.
Get the week's recalls, including Hikma Pharmaceuticals USA Inc.
Free weekly digest — every federal recall affecting your household, Hikma Pharmaceuticals USA Inc. included when it comes up. Track Hikma Pharmaceuticals USA Inc. specifically with Always-on.
Explore other recall topics
By hazard
By state
Get alerts for your household